Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8Colorectal Neoplasms 7Prostatic Neoplasms 6Stomach Neoplasms 5Lung Neoplasms 5Breast Neoplasms 5Pancreatic Neoplasms 4Endometrial Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Obesity 2Meningioma 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Esophageal Neoplasms 2Disease 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma, Basal Cell 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Surgical Wound Dehiscence 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Small Cell Lung Carcinoma 1Skull Base Neoplasms 1Skin Neoplasms 1Salivary Gland Neoplasms 1

Interventions

Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pleuropulmonary blastoma × Observation × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡